Daxor
7 hedge funds and large institutions have $269K invested in Daxor in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
0.07% more ownership
Funds ownership: 1.36% → 1.44% (+0.07%)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
21% less capital invested
Capital invested by funds: $339K → $269K (-$70K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$74.5K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$5.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.89K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$248 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$31.4K |
| 2 |
CF
Centaurus Financial
Anaheim,
California
|
-$28K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$10.7K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7K |
DXR Hedge Fund Activity: Q3 2018 in Review
7 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q3 2018, worth a combined $269K — down 21% from $339K a quarter earlier.
Fund positioning in DXR was balanced in Q3 2018: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $74.5K. The largest seller was Renaissance Technologies, cutting an estimated $31.4K.
- 7 institutional investors held Daxor (DXR) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $269K of Daxor stock for Q3 2018, down 21% quarter-over-quarter.
- 3 funds opened new Daxor positions in Q3 2018 and 3 closed out, a net change of 0 holders.
- The largest Daxor buyer in Q3 2018 was Citadel Advisors, an estimated $74.5K added.
- The largest Daxor seller in Q3 2018 was Renaissance Technologies, an estimated $31.4K sold.
Based on aggregated 13F filings for Q3 2018.